吉林大学学报(医学版) ›› 2020, Vol. 46 ›› Issue (04): 745-750.doi: 10.13481/j.1671-587x.20200413

• 基础研究 • 上一篇    

人COX1蛋白真核表达载体的构建及其生物信息学分析

董媛, 李建华, 贾俊臻, 冯文卓, 孟晨阳, 贺佳美, 唐一鑫, 王会岩   

  1. 吉林医药学院检验学院生物技术教研室, 吉林 吉林 132013
  • 收稿日期:2019-11-04 发布日期:2020-08-20
  • 通讯作者: 王会岩,教授,硕士研究生导师(Tel:0432-64560290,E-mail:zswhy518@163.com) E-mail:zswhy518@163.com
  • 作者简介:董媛(1986-),女,吉林省长春市人,讲师,理学博士,主要从事生物制药方面的研究。
  • 基金资助:
    吉林省教育厅科研项目资助课题(JJKH20180822KJ);吉林省科技厅科研项目资助课题(20180623045TC);吉林省中医药管理局科研项目资助课题(2018125);吉林省大学生创新创业训练项目资助课题(201813743007)

Construction of eukaryotic expression vector of human COX1 protein and its bioinformatics analysis

DONG Yuan, LI Jianhua, JIA Junzhen, FENG Wenzhuo, MENG Chenyang, HE Jiamei, TANG Yixin, WANG Huiyan   

  1. Department of Biotechnology, Academy of Laboratory, School of Medical Laboratory, Jilin Medical University, Jilin 132013, China
  • Received:2019-11-04 Published:2020-08-20

摘要: 目的:构建表达重组环氧合酶1(COX1)真核表达载体,验证其体外能够催化底物合成前列腺素E1(PGE1),以寻找高效获得PGE1的方法。方法:提取人微血管内皮细胞(HMECs)总RNA,逆转录成cDNA,以cDNA为模板,PCR扩增人COX1基因,经双酶切后与真核表达载体pCMV6连接,构建重组pCMV6-COX1真核表达质粒。通过生物信息学在线工具分析COX1蛋白的疏水性、跨膜区域、信号肽、二级结构和三级结构。采用脂质体将重组质粒转染至HEK-293F细胞中,将细胞随机分为对照组(未转染重组质粒的HEK-293F细胞)、转染重组质粒2 d组和转染重组质粒5 d组,分别收集细胞和细胞培养上清,Western blotting法检测COX1蛋白表达水平。比较真核表达的COX1蛋白与羊精囊提取法制备的粗酶混合物催化底物二高-γ-亚麻酸合成PGE1的酶活性。结果:经PCR、双酶切和测序鉴定,成功构建pCMV6-COX1重组载体,目的基因长度约为1800 bp。生物信息学分析,COX1蛋白为水溶性蛋白,1~53位氨基酸为信号肽,34~53位氨基酸处于跨膜区域,有36个丝氨酸磷酸化位点、14个苏氨酸磷酸化位点和9个酪氨酸磷酸化位点。二级结构预测,不规则卷曲所占比例为46.20%,其次为α螺旋占41.03%。延伸链和β-转角分别占10.18%和2.58%。Western blotting法检测,重组质粒成功转染至HEK-293F细胞中,与转染重组质粒2 d组比较,转染重组质粒5 d组细胞培养上清中COX1蛋白表达水平明显升高(P<0.05),蛋白相对分子质量为70000。当底物浓度为1%时,COX1蛋白催化底物合成PGE1的含量为(50.01±1.37) ng·L-1,其活性相当于5个羊精囊制备的粗酶活性的(90.30±0.06)%。结论:通过基因工程技术构建和表达的COX1蛋白能够催化底物合成PGE1并满足临床要求。

关键词: 前列腺素E1, 环氧合酶1, 真核表达, 重组载体, 催化活性

Abstract: Objective: To construct the eukaryotic expression vector of cycxygenase 1 (COX1) and to verify that COX1 protein can catalyze the synthesis of prostaglandin E1 (PGE1) in vitro, and to find a method to efficiently obtain PGE1. Methods: The total RNA of human microvascular endothelial cells (HMECs) was extracted and reversely transcribed into cDNA, which was served as the template to amplify the human COX1 gene by PCR. After double enzyme digestion, COX1 gene was connected with the eukaryotic expression vector pCMV6 to construct the recombinant plasmid pCMV6-COX1. Bioinformatic online softwares were used to analyze the hydrophobicity, transmembrane region, signal peptide, secondary structure and tertiary structure of COX1 protein. Afterwards, the human COX1 eukaryotic expression plasmid was expressed in the HEK-293F cells by liposomes. The cells were divided into control group (the HEK-293F cells without recombinant plasmid transfection), transfection 2 d group and transfection 5 d group. Then the cells and the cell culture supernatants were collected, respectively; the expression levels of COX1 protein were detected by Western blotting method. The activities of PGE1 synthesized by dohomo-γ-linolenic acid catalyzed by the eukaryotic expression COX1 protein and crude enzyme extract from sheep seminal vesicles were compared. Results: The recombinant plasmid pCMV6-COX1 was successfully constructed and identified by PCR, double digestion and sequencing. The length of target gene was about 1 800 bp. The bioinformatics analysis results showed that COX1 protein was a water-soluble protein. The amino acids at position 1-53 were signal peptides, the amino acids at position 34-53 were transmembrane regions; there were 36 serine phosphorylation sites, 14 threonine phosphorylation sites and 9 tyrosine phosphorylation sites. The prediction of secondary structure showed that the ratio of irregular crimp, alpha helix, extension chain and β angle were 46.20%, 41.03%, 10.18% and 2.58%, respectively.The Western blotting results showed that the recombinant plasmid was successfully transfected into the HEK-293F cells; compared with transfection 2 d group,the expression level of COX1 protein in the supernatants of the cells in transfetion 5 d group was significantly increased(P<0.05) and the relative molecular weight of protein was 70 000. When the substrate concentration was 1%, the yield of PGE1 synthesized by COX1 protein was (50.01±1.37) ng·L-1, which was equivalent to (90.3±0.06)% of the activity of crude enzyme extracted from 5 sheep seminal vesicles. Conclusion: The COX1 protein constructed and expressed by genetic engineering technology can catalyze the synthesis of PGE1 and meet the clinical requirements.

Key words: prostaglandin E1, cycxygenase 1, eukaryotic expression, recombinant vector, catalytic activity

中图分类号: 

  • Q78